Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #8538 on YaSheng Group (HERB)
aandt
12/01/22 8:24 PM
#8539 RE: RealDutch #8538
Intent for the Raise: Yasheng Group plans to raise this round for the Biotechnology segment of their company, and more specifically, for Jove Therapeutics. Yasheng Group has entered a Joint Venture with ProMab Biotechnologies, Inc, a leading antibody and cell therapy development company, to form Jove Therapeutics. The purpose of the new venture is to expand tomorrow’s cutting-edge technology for the development of multiple myeloma and other cancer treatment. The Joint Venture takes the stage of powerful cell therapeutics by bridging CAR-T/NK’s gene delivery gaps with mRNA-LNP in cancer therapy.